Literature DB >> 11064314

Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysis.

E M Yoshida1, N R Caron, A K Buczkowski, L T Arbour, C H Scudamore, U P Steinbrecher, S R Erb, S W Chung.   

Abstract

OBJECTIVES: To study the indications for liver transplantation among British Columbia's First Nation population.
MATERIALS AND METHODS: A retrospective analysis of the British Columbia Transplant Society's database of Aboriginal and non-Aboriginal liver transplant recipients from 1989 to 1998 was undertaken. For primary biliary cirrhosis (PBC), the transplant assessment database (patients with and without transplants) was analyzed using a binomial distribution and compared with published census data regarding British Columbia's proportion of Aboriginal people.
RESULTS: Between 1989 and 1998, 203 transplantations were performed in 189 recipients. Fifteen recipients were Aboriginal (n=15; 7.9%). Among all recipients, the four most frequent indications for liver transplantation were hepatitis C virus (HCV) infection (n=57; 30.2%), PBC (n=34; 18.0%), alcohol (n=22; 11.6%) and autoimmune hepatitis (n=14; 7.4%). Indications for liver transplantation among Aboriginal people were PBC (n=8; 53.3%; P<0.001 compared with non-Aboriginal people), autoimmune hepatitis (n=4; 26.67%; P=0.017), acute failure (n=2; 13.3%) and HCV (n=1). Among all patients referred for liver transplantation with PBC (n=43), 29 (67.44%) were white and 11 (25.6%) were Aboriginal. A significant difference was found between the proportion of Aboriginal people referred for liver transplantation and the proportion of Aboriginal people in British Columbia (139,655 of 3,698,755 [3.8%]; 1996 Census, Statistics Canada) (P<0.001).
CONCLUSIONS: Aboriginal people in British Columbia are more likely to be referred for liver transplantation with a diagnosis of PBC but are less likely to receive a liver transplant because of HCV or alcohol than are non-Aboriginal people.

Entities:  

Mesh:

Year:  2000        PMID: 11064314     DOI: 10.1155/2000/907463

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  8 in total

1.  Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbia's First Nations community.

Authors:  Henry V Chung; Mark Riley; Jin K Ho; Benjamin Leung; Gareth P Jevon; Laura T Arbour; Colin Barker; Richard Schreiber; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

2.  Promoting skill-building in cultural competence: A must for paediatricians who care for socially vulnerable populations.

Authors:  Saleem Razack
Journal:  Paediatr Child Health       Date:  2007-10       Impact factor: 2.253

3.  Lessons learned from liver transplantation with the Canadian First Nations.

Authors:  Aldo J Montano-Loza; Robert P Myers; Andrew L Mason
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

4.  Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia's Pacific Northwest.

Authors:  Eric-M Yoshida; Mark Riley; Laura-T Arbour
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

5.  Liver transplant outcomes in a Canadian First Nations population.

Authors:  M Zhang; J Uhanova; G Y Minuk
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

Review 6.  Chronic liver disease in Aboriginal North Americans.

Authors:  John D Scott; Naomi Garland
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

7.  Autoimmune hepatitis in a North American Aboriginal/First Nations population.

Authors:  G Y Minuk; S Liu; K Kaita; S Wong; E Renner; J Rempel; J Uhanova
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

8.  Celiac disease in native Indians from Brazil: A clinical and epidemiological survey.

Authors:  Shirley Ramos da Rosa Utiyama; João Luis Coelho Ribas; Renato Mitsunori Nisihara; Lorete Maria da Silva Kotze; Iara José de Messias-Reason
Journal:  N Am J Med Sci       Date:  2010-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.